An Open-Label Trial of Memantine for Cognitive Impairment in Patients with Posttraumatic Stress Disorder

Table 3

Estimated means and standard errors for secondary outcome scores at each visit (from ME model).

	Week	Mean	SE	value
CAPS-B	Baseline	20.65	1.73	0.52
	End of week 8	19.10	1.62
	End of week 16	19.17	1.60
CAPS-C	Baseline	33.31	1.54	0.0055
	End of week 8	27.98	2.08
	End of week 16	26.92	1.97
CAPS-D	Baseline	24.88	0.97	0.023
	End of week 8	21.88	1.58
	End of week 16	20.75	1.44
CAPS total score	Baseline	78.85	3.79	0.027
	End of week 8	68.92	4.72
	End of week 16	66.80	4.45
HAM-A	Baseline	25.04	1.71	0.056
	End of week 8	20.76	1.99
	End of week 16	20.18	1.74
HAM-D	Baseline	19.96	1.17	0.013
	End of week 8	14.57	1.36
	End of week 16	15.53	1.54
Q-LES-Q	Baseline	40.27	1.79	0.0076
	End of week 8	47.07	2.25
	End of week 16	46.81	2.21
SDS	Baseline	7.02	0.31	0.020
	End of week 8	6.20	0.66
	End of week 16	5.73	0.50